Quantcast

Latest AbbVie Inc. Stories

2014-09-19 16:24:13

NORTH CHICAGO, Ill., Sept. 19, 2014 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $0.42 per share. The cash dividend is payable Nov. 17, 2014 to stockholders of record at the close of business on Oct. 15, 2014. About AbbVieAbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. The company's mission is to use its expertise, dedicated people and unique approach to...

2014-09-15 08:25:17

NEW YORK, Sept. 15, 2014 /PRNewswire/ -- Hynes Keller & Hernandez, LLC is investigating potential claims involving World Acceptance Corp., PTC, Inc. and AbbVie Inc., as detailed below. World Acceptance Corp. ("WRLD") Hynes Keller & Hernandez, LLC is investigating potential claims against the Board of Directors at WRLD (NASDAQGS: WRLD) concerning possible breaches of fiduciary duty related to the Company's alleged issuance of false and misleading statements about its business...

2014-09-08 12:29:59

Commission Alleges That AbbVie Inc. and Besins Healthcare Inc. Filed Sham Lawsuits; AbbVie and Teva Pharmaceuticals USA, Inc. Entered Anticompetitive Agreement to Delay Generic Entry WASHINGTON, Sept. 8, 2014 /PRNewswire-USNewswire/ -- In its latest action to ensure competition in the nation's healthcare markets, the Federal Trade Commission has filed a complaint in federal district court charging several major pharmaceutical companies with illegally blocking American consumers' access to...

2014-09-03 16:29:39

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION NORTH CHICAGO, Ill., Sept. 3, 2014 /PRNewswire/ -- Following the announcement of the collaboration agreements with Calico Life Sciences LLC (Calico) and Infinity Pharmaceuticals Inc (Infinity), AbbVie is amending its earnings guidance on a GAAP basis for the year ending...

2014-09-03 08:32:32

- Infinity to Receive $275 Million Upfront Payment and $530 Million in Potential Milestones - CAMBRIDGE, Mass. and NORTH CHICAGO, Ill., Sept. 3, 2014 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) and AbbVie Inc. (NYSE: ABBV) today announced that they have entered into a global collaboration to develop and commercialize duvelisib (IPI-145), Infinity's oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, for the treatment of patients with cancer....

2014-08-26 23:14:22

Testosterone Therapy Lawsuits Continue as AndroGel Manufacturer, AbbVie Inc., Attempted to Block Perrigo’s Generic Testosterone Product from Getting FDA Approval Reports Wright & Schulte LLC Columbus, OH (PRWEB) August 26, 2014 As AbbVie faces testosterone therapy lawsuits, Wright & Schulte LLC has learned that the manufacturer of AndroGel has filed a petition against the U.S. Food & Drug Administration (FDA) for granting bioequivalence status to Perrigo Israel...

2014-07-26 23:02:52

The FDA Has Changed the Medication Guide for the Testosterone Therapy Drug AndroGel to Include The Risks of Blood Clots in the Legs and Lungs as Testosterone Treatment Lawsuits Rise to 156 Filings Reports Wright & Schulte LLC Columbus, OH (PRWEB) July 26, 2014 The U.S. Food & Drug Administration (FDA) has released an updated medical guidelines list that includes a new medication guide for AndroGel to include blood clots in the legs and lungs as a serious side-effect of taking the...

2014-07-25 08:25:24

- Reports Second-Quarter Adjusted EPS of $0.82, Above Previous Guidance Range of $0.75 to $0.77 (Reports GAAP EPS of $0.68) NORTH CHICAGO, Ill., July 25, 2014 /PRNewswire/ -- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION AbbVie (NYSE:ABBV) today announced financial results for the second quarter ended June 30,...

2014-07-18 08:24:03

DUBLIN, July 18, 2014 /PRNewswire/ -- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. Increases Non GAAP diluted earnings per ADS guidance to low-to-mid thirty percent growth in 2014. Shire (LSE: SHP, NASDAQ: SHPG) announces unaudited results for the three months to June 30, 2014....

2014-07-18 08:23:58

Infographic containing information about the recommended combination of AbbVie Inc. ("AbbVie") with Shire plc ("Shire") NORTH CHICAGO, Ill., July 18, 2014 /PRNewswire/ -- On July 18, 2014, AbbVie issued an infographic highlighting AbbVie and Shire's complementary fit and the benefits of the proposed combination. A copy of the infographic materials will be available on AbbVie's website at: http://www.abbvieinvestor.com/phoenix.zhtml?c=251551&p=irol-disclaimer-documents In...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related